Target intelligence / Profile preview

Transmembrane p24 trafficking protein 11, pseudogene (TMED11P)

Target
TMED11P
Molecular classification
Other (pseudogene, member of p24 family proteins)
01

Overview

Transmembrane p24 trafficking protein 11, pseudogene (TMED11P) is classified as a pseudogene related to the p24 (TMED) family of proteins, which play roles in protein trafficking between the endoplasmic reticulum (ER) and Golgi apparatus[3]. The TMED/p24 family consists of small type I transmembrane proteins organized into subfamilies (α, β, γ, δ) and are important for secretory pathways, but TMED11P itself is not a protein-coding gene and is unlikely to have a direct functional protein product or act as a therapeutic target[3]. Unlike active members of the p24 family, which can be involved in selective protein transport, secretion, and possibly quality control within the secretory pathway[1], TMED11P exists as a non-functional genomic remnant and is not associated with disease, drugs, or known biomarker roles. Summary of findings: - TMED11P is a pseudogene, so it does not encode an active receptor, transporter, or enzyme[3]. - It is not considered a therapeutic target, nor associated with disease or drug interaction. - Its aliases reflect classification with the p24 family, specifically the α subfamily designation ("p24alpha1, p24a1")[1][3]. - No direct biological function, molecular role, or clinical relevance is attributed to TMED11P. - This entry is not a correct therapeutic target and this should be clearly indicated in structured data extraction.

Other names
p24alpha1p24a1TMED11 pseudogenetransmembrane emp24 protein transport domain containing 11, pseudogene

Beyond the preview

Go deeper on Transmembrane p24 trafficking protein 11, pseudogene (TMED11P).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Transmembrane p24 trafficking protein 11, pseudogene (TMED11P).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call